This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Astrazeneca Ab. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2024
Title: Johan Olof Broddefalk: Innovator in Pharmaceutical Chemistry
Introduction
Johan Olof Broddefalk is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic use. With a total of 5 patents to his name, Broddefalk's work focuses on innovative solutions for treating cardiovascular diseases.
Latest Patents
Among his latest patents, Broddefalk has developed pyrazole derivatives that serve as 5-lipoxygenase activating protein (FLAP) inhibitors. These compounds are designed to treat and prevent clinical conditions, including cardiovascular diseases (CVD). The applications detail methods for their therapeutic use, pharmaceutical compositions containing these compounds, and processes for their preparation.
Career Highlights
Broddefalk is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His innovative approach has positioned him as a key player in the field.
Collaborations
Broddefalk has collaborated with several talented individuals in his field, including Kenneth Lars Granberg and Malin Anita Lemurell. These collaborations have fostered a creative environment that encourages the development of new ideas and solutions.
Conclusion
Johan Olof Broddefalk's contributions to pharmaceutical chemistry highlight his commitment to innovation and improving healthcare outcomes. His work continues to pave the way for advancements in the treatment of cardiovascular diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile